FGF16(成纤维细胞生长因子16)属于FGF基因家族,该家族包含22个成员,主要参与细胞增殖、分化、迁移和存活等生物学过程。FGF16主要在胚胎发育过程中表达,特别是在心脏、骨骼和神经系统发育中发挥重要作用。它通过结合FGF受体(FGFR)并激活下游信号通路(如MAPK和PI3K-AKT通路)来调控细胞功能。FGF16的突变可能导致发育异常,例如心脏缺陷或骨骼畸形,因为它影响了正常的心脏形态发生和肢体发育。研究表明,FGF16的异常表达与某些癌症(如乳腺癌和前列腺癌)有关,可能通过促进细胞增殖和血管生成来支持肿瘤生长。如果FGF16过表达,可能加速细胞分裂并增加肿瘤风险,而降低表达则可能影响正常组织修复和发育过程。FGF基因家族的共性包括编码分泌型或细胞内信号蛋白,通过与FGFR结合激活多种信号通路,从而调控胚胎发育、组织稳态和代谢平衡。FGF16在家族中较为独特,因其表达具有组织特异性,尤其在心脏和骨骼肌中较为显著。此外,FGF16与其他FGF成员(如FGF8和FGF20)功能部分重叠,但各自在特定发育阶段或组织中发挥主导作用。
This gene encodes a member of a family of proteins that are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene is expressed in cardiac cells and is required for proper heart development. Mutation in this gene was also observed in individuals with metacarpal 4-5 fusion. [provided by RefSeq, Mar 2014]
该基因编码的蛋白质家族中涉及多种生物学过程,包括胚胎发育,细胞生长,形态发生,组织修复,肿瘤生长和侵袭的成员。该基因在心肌细胞中表达,并需要适当心脏发育。突变在该基因与掌骨4-5融合个人也进行了观察。 [由RefSeq的,2014年3月提供]
FGF16基因(以及对应的蛋白质)的细胞分布位置:
FGF16基因的本体(GO)信息:
名称 |
---|
4014 Ras signaling pathway [PATH:hsa04014] |
4015 Rap1 signaling pathway [PATH:hsa04015] |
4010 MAPK signaling pathway [PATH:hsa04010] |
4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
4810 Regulation of actin cytoskeleton [PATH:hsa04810] |
5200 Pathways in cancer [PATH:hsa05200] |
5218 Melanoma [PATH:hsa05218] |
名称 |
---|
Activated point mutants of FGFR2 |
Adaptive Immune System |
Constitutive Signaling by Aberrant PI3K in Cancer |
DAP12 interactions |
DAP12 signaling |
Disease |
Diseases of signal transduction |
Downstream signal transduction |
Downstream signaling events of B Cell Receptor (BCR) |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
Fc epsilon receptor (FCERI) signaling |
FGFR2 ligand binding and activation |
FGFR2 mutant receptor activation |
FGFR2c ligand binding and activation |
FGFR3 ligand binding and activation |
FGFR3 mutant receptor activation |
FGFR3c ligand binding and activation |
FGFR4 ligand binding and activation |
FRS-mediated FGFR2 signaling |
FRS-mediated FGFR3 signaling |
FRS2-mediated FGFR4 signaling |
GAB1 signalosome |
IGF1R signaling cascade |
Immune System |
Innate Immune System |
Insulin receptor signalling cascade |
IRS-mediated signalling |
IRS-related events |
IRS-related events triggered by IGF1R |
Negative regulation of FGFR2 signaling |
Negative regulation of FGFR3 signaling |
Negative regulation of FGFR4 signaling |
NGF signalling via TRKA from the plasma membrane |
Phospholipase C-mediated cascade; FGFR2 |
Phospholipase C-mediated cascade; FGFR3 |
Phospholipase C-mediated cascade; FGFR4 |
PI-3K cascade:FGFR1 |
PI-3K cascade:FGFR2 |
PI-3K cascade:FGFR3 |
PI-3K cascade:FGFR4 |
PI3K Cascade |
PI3K events in ERBB2 signaling |
PI3K events in ERBB4 signaling |
PI3K/AKT activation |
PI3K/AKT Signaling in Cancer |
PIP3 activates AKT signaling |
Role of LAT2/NTAL/LAB on calcium mobilization |
SHC-mediated cascade:FGFR2 |
SHC-mediated cascade:FGFR3 |
SHC-mediated cascade:FGFR4 |
Signal Transduction |
Signaling by activated point mutants of FGFR3 |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR in disease |
Signaling by FGFR1 |
Signaling by FGFR2 |
Signaling by FGFR2 in disease |
Signaling by FGFR2 mutants |
Signaling by FGFR3 |
Signaling by FGFR3 in disease |
Signaling by FGFR3 mutants |
Signaling by FGFR4 |
Signaling by FGFR4 in disease |
Signaling by FGFR4 mutants |
Signaling by Insulin receptor |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by the B Cell Receptor (BCR) |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
Signalling by NGF |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
METACARPAL 4-5 FUSION | 0.36 | 1 | 3 | CLINVAR_ORPHANET_UNIPROT |
Neoplasm Invasiveness | 0.12 | 1 | 0 | CTD_human |
Adenoid Cystic Carcinoma | 0.12 | 1 | 0 | CTD_human |
Congenital Abnormality | 0.000542884 | 2 | 0 | BeFree |
Neonatal Deformity | 0.000542884 | 2 | 0 | BeFree |
ovarian neoplasm | 0.000271442 | 1 | 0 | BeFree |
Ovarian Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of ovary | 0.000271442 | 1 | 0 | BeFree |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。